APARICIO HERNANDEZ, R.; GARCIA LUQUE, A.; LOPEZ HONDUVILLA, F.J.    SANCHEZ JIMENEZ, F.J.. Positive assessment of drugs: September, October and November 2016. []. , 73, 1, pp.31-39. ISSN 1887-8571.

The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in September, October and November of 2016, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

: Ácido obeticólico; Ocaliva^®; Edotreótida; Somakit TOC^®; Empagliflozina/Linagliptina; Glyxambi^®; Etelcalcetide; Parsabiv^®; Folitropina delta; Rekovelle^®; Insulina Asparta; Fiasp^®; Insulina glargina/Lixisenatida; Suliqua^®; Ixazomib; Ninlaro^®; Lonoctocog Alfa; Afstyla^®; Mercaptamina hidrocloruro; Cystadrops^®; Olaratumab; Lartuvo^®; Palbociclib; Ibrance^®; Tenofovir alafenamida; Vemlidy^®; Venetoclax; Venclyxto^®.

        · |     · |     · ( pdf )